PuriBlood Medical Co (ROCO:6847) Cash-to-Debt : 2.00 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. PuriBlood Medical Co's cash to debt ratio for the quarter that ended in Jun. 2024 was 2.00.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, PuriBlood Medical Co could pay off its debt using the cash in hand for the quarter that ended in Jun. 2024.

The historical rank and industry rank for PuriBlood Medical Co's Cash-to-Debt or its related term are showing as below:

ROCO:6847' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32 Med: 2.16 Max: 130.27
Current: 2

During the past 6 years, PuriBlood Medical Co's highest Cash to Debt Ratio was 130.27. The lowest was 0.32. And the median was 2.16.

ROCO:6847's Cash-to-Debt is ranked better than
58.56% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.22 vs ROCO:6847: 2.00

PuriBlood Medical Co Cash-to-Debt Historical Data

The historical data trend for PuriBlood Medical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

PuriBlood Medical Co Cash-to-Debt Chart

PuriBlood Medical Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.32

2.95

4.33

1.76

2.28

PuriBlood Medical Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash-to-Debt	Get a 7-Day Free Trial						2.04	1.76	1.71	2.28	2.00

Competitive Comparison of PuriBlood Medical Co's Cash-to-Debt

For the Diagnostics & Research subindustry, PuriBlood Medical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PuriBlood Medical Co's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PuriBlood Medical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where PuriBlood Medical Co's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

PuriBlood Medical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

PuriBlood Medical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	117.482	/	(7.94	+	43.701)
	=	2.27

PuriBlood Medical Co's Cash to Debt Ratio for the quarter that ended in Jun. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	95.311	/	(7.94	+	39.74)
	=	2.00

PuriBlood Medical Co (ROCO:6847) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

PuriBlood Medical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

PuriBlood Medical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN

Website

https://puriblood.com

PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines